SEC Tracker
Get the app
EHSI · XBRL financial data

Elite Health Systems financial statements, every quarter

The same tables from 12 filings, lined up. Matched by XBRL tag: renamed lines keep their history.

Download Excel Download CSV
How these numbers work
  • Every number comes from the company's XBRL financial data filed with the SEC, and each one links to its filing.
  • Lines are matched by XBRL tag, so a line renamed between filings keeps its history.
  • * marks a quarter worked out from the filing totals: the 10-K year minus the first three quarters, or a year-to-date total minus the earlier one. Fourth-quarter earnings per share is fourth-quarter net income over the fourth-quarter weighted shares.
  • 0 means a filing states zero; a dash (—) means no filing states that number.
  • “year only” means the 10-K gives the full year but not the quarters needed to work out the fourth. A worked-out quarter of revenue, cost of revenue or operating cash flow more than twice the company's largest quarter of the two years before is shown this way too.
  • Gross profit is shown as the company reports it; a worked-out quarter must equal revenue less cost of revenue for that quarter, or it is a dash.
  • Operating income can be above gross profit when the company books other operating income between the two, shown on its own line.
  • Shares outstanding come from each filing's cover page, as of the date printed there.
  • Quarters are fiscal: Q2 FY27 is the second quarter of the company's fiscal 2027.

Income statement

CSV

Fiscal quarters (EHSI's year ends in late December)

In thousands of dollarsSep 30, 2023Dec 31, 2023Mar 31, 2024Jun 30, 2024Sep 30, 2024Dec 31, 2024Mar 31, 2025Jun 30, 2025Sep 30, 2025Dec 31, 2025Mar 31, 2026Jun 30, 2026
Revenue from contracts with customers00*0000*0001,024*1,3981,310
Cost of revenue—————year only00—year only1,2811,142
Gross profit—————year only—0—year only117168
Selling, general and administrative151243*476437387494*4274451,1651,921*1,4151,709
Total operating expenses151243*476—————————
Operating income (loss)(151)(243)*(476)(437)(387)(494)*(427)(445)(1,165)(1,803)*(1,298)(1,541)
Interest expense11*100———————
Other income (expense)—year only——————————
Income tax expense (benefit)00*(163)000*———year only——
Net income (loss)(127)(146)*(312)(435)(290)(1,021)*(424)(441)(1,161)(5,778)*(1,294)(1,532)
Earnings per share, basic USD per share(0.02)—(0.03)(0.03)(0.02)—(0.02)(0.02)(0.05)(0.22)*(0.05)(0.05)
Earnings per share, diluted USD per share(0.02)—(0.03)—————————
Weighted average shares, basic thousands of shares7,892—11,89913,48517,00719,060*21,08221,41021,72726,189*28,52228,522
Weighted average shares, diluted thousands of shares7,892—11,899—————————

Balance sheet

CSV

Fiscal quarters (EHSI's year ends in late December)

In thousands of dollarsSep 30, 2023Dec 31, 2023Mar 31, 2024Jun 30, 2024Sep 30, 2024Dec 31, 2024Mar 31, 2025Jun 30, 2025Sep 30, 2025Dec 31, 2025Mar 31, 2026Jun 30, 2026
Cash and cash equivalents5594661,7502,1953,1734,0343,6963,1213,9703,7582,6021,302
Accounts receivable—0——————————
Total current assets5795271,8062,2413,1914,2493,7303,1624,2734,4843,2721,828
Property and equipment, net085807466725898221,0387109
Right-of-use asset08580746672635546372819
Goodwill—————0———984984984
Total assets8711,3212,6003,0323,8044,3214,3193,9845,3116,6645,4333,917
Total current liabilities1916072,2029769394511672701,3401,3621,337
Lease liability, non-current05854473938291910000
Total liabilities2026762,2671,034143143911972911,3511,3731,348
Accumulated deficit(2,380)(2,390)(2,702)(3,137)(3,424)(4,445)(4,869)(5,310)(6,471)(12,249)(13,543)(15,075)
Total stockholders' equity5706453331,9983,6614,1784,2283,7875,0205,3134,0602,569
Total liabilities and equity8711,3212,6003,0323,8044,3214,3193,9845,3116,6645,4333,917
Common shares outstanding (cover page) thousands of shares7,89213,30513,48513,48517,38521,41021,41021,41021,94028,52228,52228,522

Cash flows

CSV

Fiscal quarters (EHSI's year ends in late December)

In thousands of dollarsSep 30, 2023Dec 31, 2023Mar 31, 2024Jun 30, 2024Sep 30, 2024Dec 31, 2024Mar 31, 2025Jun 30, 2025Sep 30, 2025Dec 31, 2025Mar 31, 2026Jun 30, 2026
Net income (loss)(127)(146)*(312)(435)(290)(1,021)*(424)(441)(1,161)(5,778)*(1,294)(1,532)
Stock-based compensation—————year only00*504*65*4141*
Depreciation and amortization—————————year only——
Net cash from operating activities(128)*(320)*(461)(455)*(72)*(527)*(297)(334)*(817)*(1,492)*(1,256)(1,353)*
Purchases of property and equipment—————year only———year only——
Net cash from investing activities(89)*227*00*0*263*(515)(241)*(225)*(83)*00*
Proceeds from issuing common stock0*0*1,745355*1,950*(3,958)*140*461*(431)*——
Net cash from financing activities0*0*1,745900*1,050*1,125*4740*1,891*1,363*10053*
Net change in cash(217)*(93)*1,284445*978*861*(338)(575)*849*(212)*(1,156)(1,300)*

Compare with peers

SIC 8093 and related industry codes, similar size. Each row is the latest quarter reported.

How peers are chosen
  • SIC 8093 and related industry codes with public float (or, where float is missing, quarterly revenue) between 0.2x and 5x the company's.
  • Each row is the latest quarter the company has reported, named in the Quarter column; when that filing is a 10-K, it is the fourth quarter, never the full year.
  • Runway shows only for companies burning cash with under $10B of public float.
  • * marks a quarter worked out from the filing totals: for a 10-Q, the year-to-date total less the earlier one.
CompanyCash ($K)Revenue, quarter ($K)Operating cash flow, quarter ($K)Shares outstandingRunwayQuarter
Elite Health Systems1,3021,310(1,353)*28.5M1.0 quarters 10-QJun 30, 2026
Cryo Cell International1,4267,8241,142*8.1M— 10-QAug 31, 2026
Mangoceuticals22969(261)*21.6M0.9 quarters 10-QJun 30, 2026
BioRestorative Therapies3,11323(3,808)25.5M0.9 quarters 10-QMar 31, 2026
Marpai1384,166(4,099)*26.8M0.0 quarters 10-QJun 30, 2026
Quipt Home Medical10,54380,9968,94144.5M— 10-QDec 31, 2025

Not investment advice. Not affiliated with the U.S. SEC.